Abstract
Children with advanced-stage neuroblastoma usually have a poor prognosis. While conventional treatment with surgery, chemotherapy, and radiation may provide some palliation, long-term survival is rare. A number of investigational therapies are being performed nationwide in an attempt to improve the progno sis for children with neuroblastoma. One such treatment is the use of 131I- metaiodobenzylguanidine. This article will review the pathophysiology of neuro blastoma, give an overview of this investigational treatment, and discuss the nursing care associated with radioactive treatment.
Get full access to this article
View all access options for this article.
